The Clorox Company (CLX) Stock Analysis

Company Overview

The Clorox Company manufactures and markets consumer and professional products worldwide, operating through four distinct segments that include Health and Wellness, Household, Lifestyle, and International. This business model positions the firm within the Consumer Defensive sector, specifically the Household & Personal Products industry, where it provides essential household and personal care goods to a global customer base. The company demonstrates significant scale with a market capitalization of $12.45B and an annual revenue of $6.76B, supported by an organizational structure comprising 7600 employees. These valuation and revenue figures indicate that Clorox maintains a substantial presence in the market, commanding a significant share of capitalization relative to its peer group while employing a large workforce to manage its extensive product portfolio across various geographic regions.

Financial Health

The company generated revenue of $6.76B over the trailing twelve months, resulting in a net income of $755.00M and an EBITDA of $1.23B, which highlights a substantial gap between top-line sales and bottom-line profit that reveals a robust cost structure involving operating expenses, taxes, and interest. Free cash flow stands at $1.00B, providing the organization with considerable financial flexibility to manage capital expenditures, service debt obligations, or pursue strategic initiatives without immediate reliance on external financing. Profitability analysis shows a gross margin of 44.2%, an operating margin of 14.0%, and a profit margin of 11.2%, indicating that the company retains a significant portion of sales revenue after accounting for the direct costs of goods sold and overhead expenses. The balance sheet reflects a total debt load of $3.22B against cash reserves of $227.00M, creating a debt-to-equity ratio of 9191.43 that suggests a highly leveraged financial position relative to shareholder equity. Liquidity assessment reveals a current ratio of 0.74, which indicates that the company's current assets are insufficient to cover its current liabilities without accessing external funding or converting fixed assets. Return metrics display a return on equity of 987.2% and a return on assets of 11.3%, figures that reveal management's effectiveness in generating substantial returns on shareholder capital despite the high leverage inherent in the equity structure.

Valuation Assessment

Valuation metrics show a P/E ratio of 16.70 based on trailing twelve-month earnings and a forward P/E of 14.97, implying that the market expects earnings growth in the future that would allow the stock to trade at a lower multiple relative to anticipated profitability. The price-to-book ratio is reported as -98.68, a negative figure that indicates the market is pricing the company significantly below its book value, which can occur in leveraged firms or those with specific accounting adjustments affecting retained earnings. Alternative valuation measures include a price-to-sales ratio of 1.84 and an EV/EBITDA of 12.61, suggesting the market values the company based on its revenue generation and cash flow potential relative to enterprise value. Price action over the last year oscillated between a 52-week high of $150.84 and a 52-week low of $96.66, with the current trading price situated below the annual peak but above the annual trough, reflecting recent market volatility. The stock exhibits a beta of 0.57, which means the price volatility of the shares is historically lower than the broader market, offering a more stable price profile during periods of general equity market turbulence.

Growth & Income

Recent performance data indicates a revenue growth rate of -0.8% and an earnings growth rate of -16.2% year-over-year, showing that earnings are declining at a faster pace than revenue, which implies rising cost pressures or margin compression that is impacting the bottom line more severely than top-line sales. As a dividend payer, the company offers a dividend yield of 4.9% with a payout ratio of 80.5%, a level that requires careful monitoring as it consumes a large portion of earnings and could become unsustainable if profitability continues to deteriorate. The high payout ratio combined with negative earnings growth suggests that the dividend may be under pressure, requiring the company to maintain strict cost controls to sustain shareholder distributions. Overall, the growth and income profile presents a scenario of a mature, high-dividend stock currently experiencing contraction in both revenue and profitability, which investors must weigh against the attractive yield offered.